Pediatric Gastroenterology, Hepatology & Nutrition

  • 제20권1호
  • /
  • Pages.55-60
  • /
  • 2017
  • /
  • 2234-8646(pISSN)
  • /
  • 2234-8840(eISSN)
대한소아소화기영양학회 (The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition)
권호 표지
DOI QR코드

DOI QR Code

Intestinal Hypoganglionosis Leading to Intestinal Failure and the Compassionate Use of OmegavenTM

  • Khalaf, Racha (Department of Medical Education, Johns Hopkins All Children's Hospital) ;
  • Karjoo, Sara (Department of Gatroenterology, Hepatology and Nutrition, Johns Hopkins All Children's Hospital) ;
  • Danielson, Paul (Department of Surgery, Johns Hopkins All Children's Hospital) ;
  • Wilsey, Michael (Department of Gatroenterology, Hepatology and Nutrition, Johns Hopkins All Children's Hospital) ;
  • Shakeel, Fauzia (Department of Neonatology, Johns Hopkins All Children's Hospital)
  • 투고 : 2016.02.25
  • 심사 : 2016.05.07
  • 발행 : 2017.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Intestinal hypoganglionosis is a rare innervation disorder that provides numerous nutritional, medical and surgical challenges. In this case report, we present a case of a newborn with intestinal hypoganglionosis leading to intestinal failure and intestinal failure-associated liver disease who responded to $Omegaven^{TM}$, a fat emulsion comprised of omega-3 fatty acids. $Omegaven^{TM}$ has been shown to be beneficial in the management of cholestatic liver injury. Clinical success with $Omegaven^{TM}$ was seen in this patient with a clear decrease in aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase and complete resolution of cholestasis with a direct bilirubin of zero within two weeks of initiation of $Omegaven^{TM}$. No current guidelines for the diagnosis and management of hypoganglionosis are available. We recommend a multidisciplinary approach and the use of novel therapies such as fat emulsions composed of omega-3 fatty acids for improved patient outcomes. Appropriate compassionate use protocols should be obtained from the Food and Drug Administration prior to initiation of $Omegaven^{TM}$.

키워드

참고문헌

  1. Schappi MG, Staiano A, Milla PJ, Smith VV, Dias JA, Heuschkel R, et al. A practical guide for the diagnosis of primary enteric nervous system disorders. J Pediatr Gastroenterol Nutr 2013;57:677-86. https://doi.org/10.1097/MPG.0b013e3182a8bb50
  2. Dingemann J, Puri P. Isolated hypoganglionosis: systematic review of a rare intestinal innervation defect. Pediatr Surg Int 2010;26:1111-5. https://doi.org/10.1007/s00383-010-2693-3
  3. Le HD, de Meijer VE, Robinson EM, Zurakowski D, Potemkin AK, Arsenault DA, et al. Parenteral fishoil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Am J Clin Nutr 2011;94:749-58. https://doi.org/10.3945/ajcn.110.008557
  4. Park HW, Lee NM, Kim JH, Kim KS, Kim SN. Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates: a systematic review and meta-analysis. J Nutr 2015;145:277-83. https://doi.org/10.3945/jn.114.204974
  5. Raptis DA, Limani P, Jang JH, Ungethum U, Tschuor C, Graf R, et al. GPR120 on Kupffer cells mediates hepatoprotective effects of ${\omega}3$-fatty acids. J Hepatol 2014;60:625-32. https://doi.org/10.1016/j.jhep.2013.11.006
  6. Venick RS, Calkins K. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease. Curr Opin Organ Transplant 2011;16:306-11. https://doi.org/10.1097/MOT.0b013e32834670eb
  7. Kelly DA. Liver complications of pediatric parenteral nutrition--epidemiology. Nutrition 1998;14:153-7. https://doi.org/10.1016/S0899-9007(97)00232-3
  8. Lacaille F, Gupte G, Colomb V, D'Antiga L, Hartman C, Hojsak I, et al. Intestinal failure-associated liver disease: a position paper of the ESPGHAN working group of intestinal failure and intestinal transplantation. J Pediatr Gastroenterol Nutr 2015;60:272-83. https://doi.org/10.1097/MPG.0000000000000586
  9. Calhoun AW, Sullivan JE. Omegaven for the treatment of parenteral nutrition associated liver disease: a case study. J Ky Med Assoc 2009;107:55-7.
  10. Cooper A, Floyd TF, Ross AJ 3rd, Bishop HC, Templeton JM Jr, Ziegler MM. Morbidity and mortality of shortbowel syndrome acquired in infancy: an update. J Pediatr Surg 1984;19:711-8. https://doi.org/10.1016/S0022-3468(84)80357-7
  11. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1998;27:131-7. https://doi.org/10.1097/00005176-199808000-00001